FDA seeks input on using HL7 FHIR standard for collecting RWD
Regulatory NewsJoanne S. Eglovitch
Clinical TrialsHealth Authority meeting and communication strategyPharmaceuticalsRegulatory Intelligence/PolicyRWE/RWDStandardsUnited StatesUS Food and Drug Administration (FDA)